CALLAN JMB INC. Annual Report - How They Did This Year

I’m putting together a plain-English guide to help you understand how Callan JMB Inc. (ticker: CJMB) performed this year. My goal is to explain their business strategy so you can decide if this company fits your goals, without the confusing financial jargon.

1. What does this company do?

Callan JMB is a high-tech logistics company specializing in cold-chain storage. They move sensitive items—like vaccines and medicines—that must stay frozen between -20°C and -80°C to remain effective.

They operate using a "rent-to-rent" model: they lease industrial warehouses, invest approximately $1.2 million per site to install specialized cooling systems and backup power, and then lease that space to pharmaceutical clients on multi-year contracts. Their operations are supported by proprietary Ship2Q® software and Sentry hardware sensors, which allow for real-time shipment tracking.

2. Financial Health: The "Startup" Reality

Callan JMB is currently in a growth phase where expenses exceed revenue.

• Profitability: In 2025, the company reported a loss of $8.2 million on $14.5 million in revenue. This follows a 2024 performance where they lost $2.3 million on $9.8 million in revenue.
• Cash Position: The company maintains a burn rate of approximately $650,000 per month. As of December 31, 2025, they held $4.1 million in cash. Based on current projections, this capital is expected to sustain operations until late 2026. To fund further expansion, the company may need to raise additional capital through debt or the issuance of new shares, which could dilute existing shareholder ownership.

3. Major Risks: What to watch

• Customer Concentration: Revenue is highly dependent on a small group of clients. In 2025, the top three customers accounted for 79% of total revenue. The departure of a single major client earlier in the year resulted in a 12% drop in quarterly revenue.
• Supply Chain Fragility: The company relies on a single manufacturer in Southeast Asia for their cooling sensors. Delays in this supply chain directly impact their ability to open new facilities; currently, 14 sites are awaiting these sensors.
• Operational Efficiency: The "rent-to-rent" model carries fixed costs regardless of occupancy. Currently, 22% of their warehouse space is vacant, resulting in a monthly overhead of $115,000 without corresponding income.
• Liability and Insurance: Handling high-value medical inventory carries significant risk. A cooling failure could jeopardize up to $5 million in inventory per shipment, while the company’s insurance coverage is capped at $10 million.
• Leadership and Debt: The current management team has less than two years of experience in the public sector. Additionally, the company is subject to a "key person" clause: if founder Wayne Williams leaves, the company may be required to immediately repay $3.5 million in debt.

4. The Path Forward

The company’s strategic goal is to reach 50 active facilities by 2028. They are currently pursuing partnerships to integrate their software with global shipping giants. Achieving this scale requires an estimated $25 million in capital over the next three years. Management anticipates that this expansion will lower operating costs by 30% and lead to a break-even point by late 2027.

5. The Bottom Line

Callan JMB is a high-risk, high-reward opportunity. While they have established a clear niche in specialized logistics, their success depends on their ability to diversify their client base, manage their cash burn, and successfully scale their facility network. Before investing, consider whether you are comfortable with the potential for share dilution and the operational risks associated with their current growth strategy.